Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin

European Journal of Endocrinology
Mojca Jensterle SeverAndrej Janez

Abstract

The effect of metformin on weight reduction in polycystic ovary syndrome (PCOS) is often unsatisfactory. In this study, we investigated the potential add-on effect of treatment with the glucagon-like peptide-1 receptor agonist liraglutide on weight loss in obese nondiabetic women with PCOS who had lost <5% body weight during pretreatment with metformin. A total of 40 obese women with PCOS, who had been pretreated with metformin for at least 6 months, participated in a 12-week open-label, prospective study. They were randomized to one of three treatment arms: metformin (MET) arm 1000 mg BID, liraglutide (LIRA) arm 1.2 mg QD s.c., or combined MET 1000 mg BID and LIRA (COMBI) 1.2 mg QD s.c. Lifestyle intervention was not actively promoted. The primary outcome was change in body weight. Thirty six patients (aged 31.3 ± 7.1 years, BMI 37.1 ± 4.6 kg/m²) completed the study: 14 on MET, 11 on LIRA, and 11 on combined treatment. COMBI therapy was superior to LIRA and MET monotherapy in reducing weight, BMI, and waist circumference. Subjects treated with COMBI lost on average 6.5 ± 2.8 kg compared with a 3.8 ± 3.7 kg loss in the LIRA group and a 1.2 ± 1.4 kg loss in the MET group (P<0.001). The extent of weight loss was stratified: a tot...Continue Reading

References

Sep 1, 1989·The Journal of Clinical Endocrinology and Metabolism·R Azziz, H A Zacur
Oct 25, 2003·BMJ : British Medical Journal·Jonathan M LordRobert J Norman
Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Aug 28, 2004·Diabetes·Helena GyllingTatu A Miettinen
Nov 13, 2004·The Journal of Clinical Endocrinology and Metabolism·V JayagopalS L Atkin
May 12, 2005·The Journal of Clinical Endocrinology and Metabolism·Lyndal R HarborneRichard Fleming
Jan 8, 2008·The Journal of Clinical Endocrinology and Metabolism·Thomas B Clarkson
Mar 28, 2008·Nature Clinical Practice. Endocrinology & Metabolism·Andrea Dunaif
May 8, 2008·The Journal of Clinical Endocrinology and Metabolism·Karen Elkind-HirschRajat Bhushan
Dec 4, 2008·The Journal of Clinical Endocrinology and Metabolism·Stephen C Woods, David A D'Alessio
Apr 2, 2009·The Journal of Clinical Endocrinology and Metabolism·Rania Abu-HamdahDariush Elahi
Aug 5, 2009·Expert Opinion on Therapeutic Targets·Renato Pasquali, Alessandra Gambineri
Oct 21, 2009·European Journal of Endocrinology·Evanthia Diamanti-KandarakisFrangiskos N Economou
Jan 5, 2011·Diabetologia·E A Ryan
Nov 29, 2011·Clinical Science·Benoit ViolletFabrizio Andreelli
Mar 22, 2012·Obesity Facts·Johannes Hebebrand
Oct 18, 2012·Seminars in Reproductive Medicine·Richard S Legro
Nov 28, 2012·The Journal of Clinical Endocrinology and Metabolism·Wenjing HuGangyi Yang
Dec 12, 2012·Hormones and Behavior·Colin Saldanha, Farida Sohrabji
Feb 19, 2013·Trends in Endocrinology and Metabolism : TEM·Jens Juul Holst, Carolyn F Deacon

❮ Previous
Next ❯

Citations

May 23, 2014·European Journal of Endocrinology·Gerard ConwayUNKNOWN ESE PCOS Special Interest Group
May 6, 2014·Endocrine·Jing MaWei Liu
Aug 12, 2014·Journal of Endocrinological Investigation·G MuscogiuriA Colao
Dec 15, 2015·Archives of Gynecology and Obstetrics·Mitra NiafarNader Nader
Sep 29, 2015·Journal of Atherosclerosis and Thrombosis·Yoshihiro KomoharaMotohiro Takeya
Feb 17, 2015·Diabetic Medicine : a Journal of the British Diabetic Association·D Greco
Mar 3, 2015·Fertility and Sterility·Wendy VitekKathleen M Hoeger
Sep 16, 2014·Frontiers in Endocrinology·Christina B Rasmussen, Svend Lindenberg
May 14, 2016·The Nurse Practitioner·Katherine Pereira, Kathryn Evans Kreider
Jun 25, 2017·Diabetes Research and Clinical Practice·Djuro MacutMirjana Doknić
Aug 18, 2017·Physiology·Licy L Yanes CardozoJane F Reckelhoff
Oct 7, 2015·Clinical Medicine Insights. Endocrinology and Diabetes·Nasrullah K GhumanMouza M Al Ali
Aug 2, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·F-F WangP J Hardiman
Aug 16, 2016·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Diana IsaacsSneha Baxi Srivastava
Feb 2, 2019·Current Pharmaceutical Design·Xiangyan RuanAlfred O Mueck
May 23, 2020·The Journal of Clinical Endocrinology and Metabolism·Hellas CenaRossella E Nappi
Jun 9, 2015·World Journal of Hepatology·Fátima Higuera-de la Tijera, Alfredo I Servín-Caamaño
Jun 4, 2020·The Journal of Clinical Endocrinology and Metabolism·Chuan XingBing He
Mar 10, 2017·Expert Review of Clinical Pharmacology·Elizabeth Mary LamosStephen N Davis
Jun 26, 2020·Clinical Drug Investigation·Georgios S PapaetisChristina S Stylianou
May 20, 2015·The Annals of Pharmacotherapy·Jennifer N Clements, Kayce M Shealy
Jul 2, 2019·Human Reproduction Update·Mojca JensterleSarah E Siegelaar
Jun 6, 2020·Therapeutic Advances in Endocrinology and Metabolism·Ruiyang PuNing Cheng
May 19, 2020·Minerva pediatrica·Maria E StreetPaolo Moghetti
May 25, 2016·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·W Timothy GarveyUNKNOWN Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines
Dec 22, 2020·Clinical Obstetrics and Gynecology·Jennifer M Burgart
Oct 14, 2019·Reproductive Biology·Beata BanaszewskaRobert Spaczynski
Dec 19, 2020·International Journal of Molecular Sciences·Andrea CignarellaCarla Scaroni
Dec 15, 2020·Frontiers in Endocrinology·Jing OuyangJean-Pierre Routy

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray
contraception

Clinical Trials Mentioned

NCT01911468

Software Mentioned

QDR
SPSS
Excel

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.